Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||Advanced Solid Tumor||not applicable||Gemcitabine + MK-8776||Phase I||Actionable||In a Phase I trial, the combination treatment of MK-8776 and Gemzar (gemcitabine) in patients with advanced solid tumors resulted in antitumor efficacy, including 2 patients with a partial response and 13 patients experiencing stable disease (PMID: 25605849).||25605849|